Clinical Trials Directory

Trials / Completed

CompletedNCT07100912

Human Skin Safety Testing of 6 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

A Modified Draize Repeat Insult Patch Test in a Shared Panel of 100 Healthy Volunteers to Investigate the Irritation and Sensitization Potential of 6 Test Articles Following Repeated Cutaneous Patch Applications

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
113 (actual)
Sponsor
Amazentis SA · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to investigate the irritation and sensitization potential of 6 different topically applied test articles containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method

Conditions

Interventions

TypeNameDescription
OTHERMitopure Topical Formula 5Topical skin cream containing Mitopure
OTHERMitopure Topical Formula 6Topical skin cream containing Mitopure
OTHERMitopure Topical Formula 7Topical skin cream containing Mitopure
OTHERMitopure Topical Formula 8Topical skin serum containing Mitopure
OTHERMitopure Topical Formula 9Topical skin exfoliator containing Mitopure
OTHERMitopure Topical Formula 10Topical skin cleanser containing Mitopure

Timeline

Start date
2025-08-18
Primary completion
2025-09-26
Completion
2025-09-26
First posted
2025-08-03
Last updated
2025-11-17

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07100912. Inclusion in this directory is not an endorsement.